Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07402018 · ClinicalTrials.gov registry record
Intra-aortic Balloon Counterpulsation (IABC) Compliance
A clinical trial of Cardiogenic Shock and IABC Procedure, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT07402018: Recruiting study of Cardiogenic Shock and IABC Procedure, sponsored by Thomas Jefferson University.
NCT07402018 is a study of Cardiogenic Shock and IABC Procedure that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 20 participants, below the 633-participant average among 16 other Cardiogenic Shock trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07402018, a study of Cardiogenic Shock and IABC Procedure, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators intend to study how baseline arterial compliance (as defined by stroke volume/pulse pressure) influences the clinical success of intraaortic balloon counterpulsation (IABC) in patients with cardiogenic shock (CS). The investigators aim to compare clinical outcomes in CS patients requiring IABC with normal compliance versus low compliance. The study will enroll patients undergoing IABC that are clinically indicated. Baseline hemodynamic measurements will be obtained and then patients would be stratified based on their compliance. Post IABC, serial hemodynamic measurements will be obtained and compared between groups. Patients will continue to be followed longitudinally until the IABC has been discontinued for any reason. The proposed study will yield results that will aid in developing a larger clinical trial and ultimately assist clinicians in determining if IABC is appropriate therapy for patients in cardiogenic shock.
Conditions Studied
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-01-27 |
| Est. Completion | 2026-12-31 |
What NCT07402018 shows while recruiting
NCT07402018 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 633-participant average among 16 other Cardiogenic Shock trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Cardiogenic Shock appearing as the primary indexed condition, and to 0 interventions.
NCT07402018 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07402018 about?
NCT07402018 is a clinical study titled "Intra-aortic Balloon Counterpulsation (IABC) Compliance". The investigators intend to study how baseline arterial compliance (as defined by stroke volume/pulse pressure) influences the clinical success of intraaortic balloon counterpulsation (IABC) in patients with cardiogenic shock (CS). The investigators aim to compare clinical outcomes in CS patients re...
What is the current status of trial NCT07402018?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2026-01-27. Estimated completion is 2026-12-31.
What conditions does trial NCT07402018 study?
This clinical trial studies the following conditions: Cardiogenic Shock, IABC Procedure, Intraaortic Balloon Counterpulsation (IABC).
Who is sponsoring clinical trial NCT07402018?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07402018 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiogenic Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07402018's enrollment target sits among peer trials
20 15th of 16 higher than 1 of 16 other Cardiogenic Shock trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiogenic Shock trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Cardiac Power Output in Cardiogenic Shock Patients
RECRUITING · Early Phase 1
-
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
RECRUITING
-
Inova Cardiogenic Shock Registry (INOVA SHOCK)
RECRUITING
-
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
RECRUITING
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI